{
    "organizations": [],
    "uuid": "bf1b39dd6f720091fcc2c2c94405af581ffdd794",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-eurocine-vaccines-gets-authorized/brief-eurocine-vaccines-gets-authorized-to-conduct-phase-i-ii-clinical-study-idUSFWN1P60XE",
    "ord_in_thread": 0,
    "title": "BRIEF-Eurocine Vaccines Gets Authorized To Conduct Phase I/II Clinical Study",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 11 (Reuters) - EUROCINE VACCINES AB:\n* EUROCINE VACCINES OBTAINS AUTHORIZATION TO CONDUCT THE NEXT STUDY WITH IMMUNOSE™ FLU\n* GOT AUTHORIZATION TO CONDUCT A PHASE I/II CLINICAL STUDY ON QUADRIVALENT INFLUENZA VACCINE CANDIDATE IMMUNOSE™ FLU\n* RESULTS CAN BE EXPECTED SECOND HALF OF 2018. * AUTHORIZATIONS TO CONDUCT STUDY RECEIVED FROM ‍SWEDISH MEDICAL PRODUCTS AGENCY AND ETHICS COMMITTEE​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)\nOur Standards: The Thomson Reuters Trust Principles.",
    "published": "2018-01-11T23:00:00.000+02:00",
    "crawled": "2018-01-12T18:47:07.013+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "eurocine",
        "vaccine",
        "ab",
        "eurocine",
        "vaccine",
        "obtains",
        "authorization",
        "conduct",
        "next",
        "study",
        "flu",
        "got",
        "authorization",
        "conduct",
        "phase",
        "clinical",
        "study",
        "quadrivalent",
        "influenza",
        "vaccine",
        "candidate",
        "flu",
        "result",
        "expected",
        "second",
        "half",
        "authorization",
        "conduct",
        "study",
        "received",
        "medical",
        "product",
        "agency",
        "ethic",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom",
        "standard",
        "thomson",
        "reuters",
        "trust",
        "principle"
    ]
}